Professor Nicholas PJ Day
MORU aims to fight the infectious tropical diseases affecting rural communities in Asia and elsewhere in the developing world. MORU's malaria research aims to directly improve the treatment of the disease globally. It's researchers focus on the treatment of severe malaria, the spread of antimalarial drug resistance, and the pathophysiology of falciparum and vivax malaria. These studies are used to formulate novel adjuvant therapies, and have been translated into recommendations for the use of artemisinin based combination therapies.
MA BM BCh DM FRCP FMedSci
Professor of Tropical Medicine
- Director of the Mahidol Oxford Tropical Medicine Research Unit, Thailand, and of the Wellcome Trust Thailand Asia and Africa Programme
Nick Day's interests include the epidemiology, diagnosis, pathophysiology, pathogen biology, treatment and prevention of malaria, rickettsial diseases including scrub typhus, melioidosis, leptospirosis, rickettsial infections, influenza, dengue and other communicable diseases afflicting rural populations throughout Asia and beyond. Cross-cutting interests include the drivers and epidemiology of AMR, and the syndromic management of febrile illnesses and sepsis in LMIC settings.
Miotto O. et al, (2015), Nature Genetics, 47, 226 - 234
Mok S. et al, (2015), Science, 347, 431 - 435
Maude RR. et al, (2014), The American Journal of Tropical Medicine and Hygiene, 91, 580 - 583
Lubell Y. et al, (2014), PLoS Medicine, 11, e1001704 - e1001704
Ashley EA. et al, (2014), New England Journal of Medicine, 371, 411 - 423
Chandna A. et al, (2021), Wellcome Open Research, 6, 64 - 64
Elliott I. et al, (2021), Infect Genet Evol, 91
Ahouidi A. et al, (2021), Wellcome Open Research, 6, 42 - 42
Booraphun S. et al, (2021), BMJ Open, 11
Fen SHY. et al, (2021), Antimicrob Agents Chemother